866-997-4948(US-Canada Toll Free)

Meridian Bioscience, Inc. (VIVO) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 33 Pages


Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company. It undertakes research, development, manufacture, sale and distribution of a wide range of diagnostic test kits, purified reagents and related products. The company also offers biopharmaceutical enabling technologies and a variety of biological and non-biological materials for use in proficiency testing programs. Meridian\'s strong therapeutic areas are gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. The company also undertakes contract development and manufacturing of specialty biologicals, antigens, antibodies, reagents and related technologies used by biopharmaceutical companies, other diagnostic manufacturers and researchers. Meridian markets its products to hospitals, veterinary testing centers, reference laboratories, research centers, physician offices and diagnostics manufacturers in over 60 countries throughout the world. Meridian is headquartered in Ohio, the US.

Meridian intends to form development and marketing partnerships, research collaborations, technology in-licensing with other companies which would enhance the companys capabilities, clinical program and product pipeline. It recently signed an agreement with Premier Healthcare Alliance. The company focuses on its product portfolio expansion by building strong operating base besides gaining expertise through agreements and collaborations. This intent is reflected from the recent launch of SensiFAST, a product for gene mutations and SNP Analysis.

This report is a source for data, analysis and actionable intelligence on the Meridian Bioscience, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Meridian Bioscience, Inc. - Business Description 4

Key Facts 5
Meridian Bioscience, Inc. - Major Products and Services 6
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 9
Meridian Bioscience, Inc. Pipeline Products by Development Stage 11
Meridian Bioscience, Inc. Pipeline Products by Therapy Area 13
Illumigene Mycoplasma Assay 15
Illumigene Mycoplasma Assay Product Status 15
Illumigene Mycoplasma Assay Product Description 15
Illumigene Pertussis Assay 16
Illumigene Pertussis Assay Product Status 16
Illumigene Pertussis Assay Product Description 16
Illumipro-10 System - Bordetella Assay 17
Illumipro-10 System - Bordetella Assay Product Status 17
Illumipro-10 System - Bordetella Assay Product Description 17
Illumipro-10 System - CT Assay 18
Illumipro-10 System - CT Assay Product Status 18
Illumipro-10 System - CT Assay Product Description 18
Illumipro-10 System - Mycoplasma Assay 19
Illumipro-10 System - Mycoplasma Assay Product Status 19
Illumipro-10 System - Mycoplasma Assay Product Description 19
Illumipro-10 System - NG Assay 20
Illumipro-10 System - NG Assay Product Status 20
Illumipro-10 System - NG Assay Product Description 20
Meridian Bioscience, Inc. - Key Competitors 21
Meridian Bioscience, Inc. - Key Employees 22
Meridian Bioscience, Inc. - Key Employee Biographies 23
Meridian Bioscience, Inc. - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Meridian Bioscience, Inc., Recent Developments 26
Nov 08, 2012: Meridian Bioscience Reports Revenue Of $173.5m In Fiscal 2012 26
Jul 26, 2012: Meridian Bioscience Reports Revenue Of $42.1m In Q3 Fiscal 2012 26
Apr 26, 2012: Meridian Bioscience Reports Revenue Of $47.4m In Q2 Fiscal 2012 27
Apr 12, 2012: Meridian Signs New Agreement with Premier For Molecular Diagnostic Tests And Instruments For C. difficile And Group B Streptococcus 28
Jan 25, 2012: Meridian Bioscience Reports Revenue Of $40.3m In Q1 Fiscal 2012 29
Nov 10, 2011: Meridian Bioscience Reports Revenue Of $159.7m In Fiscal 2011 30
Aug 23, 2011: Meridian Bioscience Establishes Direct Sales In Australia Through Bioline Australia 31
Jul 21, 2011: Meridian Bioscience Reports Net Sales Of $40.1m In Q3 Fiscal Year Ended 2011 31
Jun 10, 2011: Meridian Tests Detect Deadly Toxins Produced By E. coli O104 Outbreak Strain 32
Apr 21, 2011: Meridian Bioscience Reports Net Sales Of $41m In Q2 Fiscal Year Ended 2011 32

Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Table


Meridian Bioscience, Inc., Key Facts 1
Meridian Bioscience, Inc. Key Pipeline Products by Equipment Type 1
Meridian Bioscience, Inc. Key Pipeline Products by Therapy Area 1
Meridian Bioscience, Inc. Key Pipeline Products by Development Stage 1
Meridian Bioscience, Inc., Key Facts 5
Meridian Bioscience, Inc., Major Products and Services 6
Meridian Bioscience, Inc. Number of Pipeline Products by Equipment Type 9
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 10
Meridian Bioscience, Inc. Number of Pipeline Products by Development Stage 11
Meridian Bioscience, Inc. Pipeline Products by Development Stage 12
Meridian Bioscience, Inc. Number of Pipeline Products by Therapy Area 13
Meridian Bioscience, Inc. Pipeline Products by Therapy Area 14
Illumigene Mycoplasma Assay - Product Status 15
Illumigene Mycoplasma Assay - Product Description 15
Illumigene Pertussis Assay - Product Status 16
Illumigene Pertussis Assay - Product Description 16
Illumipro-10 System - Bordetella Assay - Product Status 17
Illumipro-10 System - Bordetella Assay - Product Description 17
Illumipro-10 System - CT Assay - Product Status 18
Illumipro-10 System - CT Assay - Product Description 18
Illumipro-10 System - Mycoplasma Assay - Product Status 19
Illumipro-10 System - Mycoplasma Assay - Product Description 19
Illumipro-10 System - NG Assay - Product Status 20
Illumipro-10 System - NG Assay - Product Description 20
Meridian Bioscience, Inc., Key Employees 22
Meridian Bioscience, Inc., Key Employee Biographies 23
Meridian Bioscience, Inc., Other Locations 24
Meridian Bioscience, Inc., Subsidiaries 24

List of Chart

 
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 9
Meridian Bioscience, Inc. Pipeline Products by Development Stage 11
Meridian Bioscience, Inc. Pipeline Products by Therapy Area 13

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *